CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
2023; Nature Portfolio; Volume: 29; Issue: 7 Linguagem: Inglês
10.1038/s41591-023-02404-6
ISSN1546-170X
AutoresJae H. Park, Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah, Parastoo B. Dahi, Richard J. Lin, Michael Scordo, Miguel‐Angel Perales, Roni Shouval, Ana Alarcón Tomás, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei I. Holodny, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain,
Tópico(s)Advancements in Semiconductor Devices and Circuit Design
Referência(s)